TRENTON, N.J. — BioNJ, the trade association for New Jersey’s life science industry, today announced it has renewed its 16-year Primary Supplier Agreement with Fisher Scientific, part of Waltham-based Thermo Fisher Scientific Inc. This agreement enables BioNJ Members to achieve significant savings on laboratory supplies and a variety of other services. “Our Members have already […]
LANSING, Mich. – Neogen Corporation (Nasdaq: NEOG) announced today that it has introduced a “clearly better” test system for microbial counts. Neogen’s new NeoFilm™ microbial tests require only the inoculation of a fabric sample pad and an incubation period. Following incubation, the sample pad is evaluated for bacterial colony growth. NeoFilm tests are available for […]
FORT COLLINS, Colo. — Ventria Bioscience today announced that Margaret B. Glick, Ph.D., CPA has been appointed as the company’s new vice president of finance. Dr. Glick will oversee all financial and related administrative functions for the company. “Maggie comes to Ventria Bioscience with expertise in private and public corporate finance as well as organizational […]
AMSBIO has introduced a new range of neural progenitor cells, and cerebral cortical neurons, derived from human induced pluripotent stem (iPS) cells. Despite the large investment and interest in neuroscience traditional methods of studying the human nervous system and disease pathogenesis and mechanisms required the generation of animal models. However, these methods are time consuming, […]
WALTHAM, Mass. — Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, today announced that it has received approval from the European Commission (EC) for its pending acquisition of Life Technologies Corporation (NASDAQ: LIFE). To expedite the approval, Thermo Fisher has committed to divest of its cell culture (sera and media), gene modulation […]
CAMBRIDGE, MASS. — Editas Medicine, a transformative genome editing company, today announced it has secured a $43 million Series A financing led by Flagship Ventures, Polaris Partners and Third Rock Ventures with participation from Partners Innovation Fund. Following an explosion of high profile publications on CRISPR/Cas9 and TALENs, genome editing has emerged as one of […]
Beauvoir – Stiplastics, an industrial SME which designs, develops, manufactures and markets technical products and innovative devices principally made of injected plastic material, particularly for the healthcare market, launches the fifth generation of its Hemobox® carry case and associated accessories. A case which is continually evolving to offer enhanced safety and productivity The first Hemobox® […]
Drawing upon many years’ experience,AMSBIO has developed a custom phospho-specific antibody production service that is both reliable and produces highly specific quality antisera. Phospho-specific antibodies are widely accepted for use in defining regulatory mechanisms that control cell functions such as activation of enzymes and receptors, cellular transcription, signal transduction, and cell signalling networks. Phospho-specific antibodies […]
Cambridge, UK — Horizon Discovery (Horizon) has won “Licensing Deal of the Year” at the Scrip Awards 2013, for their agreement with AstraZeneca to explore Horizon’s first-in-class kinase target program HD-001 as a means of developing novel therapies for multiple cancer types. The Scrip Awards are highly prestigious, recognizing excellence in both pharma and biotech […]
CORALVILLE, IA — Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, has launched the latest addition to its portfolio of next generation sequencing (NGS) products, xGen® Universal Blocking Oligos. By incorporating these oligos into target capture experiments, users can decrease the complexity and increase throughput of their target capture experiment without degradation of […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
